TECHNOLOGIES

Our focus is on patent-protected technology platforms built upon fundamental research that promise to disrupt the existing chemical and pharmaceutical industries.



Ultrahigh-throughput Small Molecule Drug Discovery using Computational Biophysics, Artificial Intelligence, and DNA Encoded Libraries

Patents

  • Methods for the design of mechanism-based sirtuin activating compounds.US Patent 11,118,211 B2 (2021)
  • Methods for the design of mechanism-based sirtuin activating compounds. US Patent 11,459,597 (2022)
  • Methods for the design of nonallosteric sirtuin activating compounds. US patent application 2022/0002778 A1 (2021)
  • Sirtuin modulating compounds and applications thereof. US patent application 18/090,953 (2022)

Licensees: CCM Protein Upregulation, Inc.

Learn more





Passively and Actively Targeted Drug Delivery using Computational Biophysics,  Nanotechnology, and Phage Display

Patents
  • Amphiphilic polyamino acid block copolymers and nanoparticles thereof for drug delivery applications.EP patent application 22305766.2 – 1102, Filed 2022
  • New EGFRvIII-binding peptides, conjugates and uses thereof. European patent application B77140EP; International patent application PCT/EP2022/087500, Filed 2022
  • Compositions and methods for silencing of KRAS.International patent application PCT/US2022/047291, Filed 2022

Licensees: CCM Nanothera Sciences; CCM RAS Sciences, Inc.

Learn more





Ultrahigh-throughput Enzyme Engineering using Computational Biophysics, Artificial Intelligence, and Microfluidic Droplet Based Selection

Patents
  • System and methods for determination of temperature cycling protocols for polymerase chain reactions. US Patent 10,861,586 B2 (2020)
  • System and methods for determination of temperature cycling protocols for polymerase chain reactions. EP Patent 3,000,366 B1 (2020)
  • System and methods for determination of temperature cycling protocols for polymerase chain reactions: optimally controlled PCR. US patent application 2019/0182944 A1, Filed 2019

  • System for determination of temperature cycling protocols for polymerase chain reactions: polymerase extension. US patent application 2019/0279739 A1, Filed 2019
  • System for determination of temperature cycling protocols for polymerase chain reactions: oligonucleotide annealing. US patent application 2019/0270189245, Filed 2019
  • System for determination of temperature cycling protocols for polymerase chain reactions: DNA melting. US patent application 2019/0295686 A1, Filed 2019
  • Polymerases for mixed aqueous-organic media and uses thereof,  International patent application PCT/US2022/011076. Filed 2022
  • Compositions and methods for enhancing PCR and other polynucleotide amplification reactions. US Patent 6,949,368 (2005)
  • Compositions and methods for enhancing polynucleotide amplification reactions. US Patent 7,276,357 (2007)
  • Chemical PCR: Compositions and methods for enhancing polynucleotide amplification reactions. US Patent 7,772,383 (2010)

Licensees: Celera Diagnostics, Quest Diagnostics, Abbott Laboratories, New England Biolabs, Toyobo, Sekisui Diagnostics, CCM 5Prime Sciences, Inc.

Learn more